The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2015-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajpheart.00172.2015PMID 26092985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor angiogenesis

  2020cited by this paper
• Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy

  2015cited by this paper
• Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.

  2014influential reference
• Recognizing and Managing Left Ventricular Dysfunction Associated With Therapeutic Inhibition of the Vascular Endothelial Growth Factor Signaling Pathway

  2014cited by this paper
• Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.

  2014cited by this paper
• Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.

  2014cited by this paper
• Cardiotoxicity Associated with the Tyrosine Kinase Inhibitor Sunitinib

  2013influential reference
• Increasingly sensitive assays for cardiac troponins: a review.

  2013cited by this paper
• Echocardiography and vascular ultrasound: new developments and future directions.

  2013influential reference
• Increasingly Sensitive Assays for Cardiac Troponins: A Review

  2013cited by this paper
• The hallmarks of cancer

  2012influential reference
• Chemotherapy-induced cardiotoxicity: role of the conventional echocardiography and the tissue Doppler.

  2011cited by this paper
• Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.

  2011influential reference
• The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity.

  2011influential reference
• Cardiovascular effects of systemic cancer treatment.

  2011cited by this paper
• Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase

  2011cited by this paper
• The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.

  2011cited by this paper
• Heart Failure Associated with Sunitinib: Lessons Learned from Animal Models

  2011cited by this paper
• Role of biomarkers in cardioncology

  2011cited by this paper
• Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels

  2010cited by this paper
• Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation.

  2010influential reference
• Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?

  2010cited by this paper
• Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study

  2010cited by this paper
• Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging.

  2010cited by this paper
• A high-lipid diet potentiates left ventricular dysfunction in nitric oxide synthase 3-deficient mice after chronic pressure overload.

  2010influential reference
• Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab.

  2009cited by this paper
• Cardiovascular toxicity caused by cancer treatment: strategies for early detection.

  2009cited by this paper
• Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy.

  2009influential reference
• Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.

  2009cited by this paper
• [Anthracycline-induced cardiomyopathy].

  2009cited by this paper
• The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure.

  2009cited by this paper
• Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?

  2008cited by this paper
• Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate.

  2008cited by this paper
• Inhibition of Vascular Endothelial Growth Factor-A Signaling Induces Hypertension: Examining the Effect of Cediranib (Recentin; AZD2171) Treatment on Blood Pressure in Rat and the Use of Concomitant Antihypertensive Therapy

  2008cited by this paper
• Validation of volume-pressure recording tail-cuff blood pressure measurements.

  2008cited by this paper
• Tumor angiogenesis.

  2008cited by this paper
• Natriuretic peptides: biochemical markers of anthracycline cardiac toxicity?

  2008cited by this paper
• Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems

  2008cited by this paper
• Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib

  2008cited by this paper
• Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

  2007influential reference
• Sunitinib: from rational design to clinical efficacy.

  2007influential reference
• Disruption of Nitric Oxide Synthase 3 Protects Against the Cardiac Injury, Dysfunction, and Mortality Induced by Doxorubicin

  2007cited by this paper
• Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.

  2007cited by this paper
• Natriuretic peptides and therapeutic applications

  2007cited by this paper
• Tissue Doppler Imaging

  2007cited by this paper
• Myocardial regulatory proteins and heart failure

  2006cited by this paper
• Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes.

  2006cited by this paper
• Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.

  2006cited by this paper
• Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury.

  2006cited by this paper
• Inflammatory biomarkers in heart failure.

  2006cited by this paper
• Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy.

  2005cited by this paper
• Quantitative Assessment of Regional Myocardial Function in Mice by Tissue Doppler Imaging: Comparison With Hemodynamics and Sonomicrometry

  2005cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Bevacizumab: An Angiogenesis Inhibitor with Efficacy in Colorectal and Other Malignancies

  2004cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale.

  2003cited by this paper
• Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer.

  2003influential reference
• Preclinical models of bone metastases.

  2001cited by this paper
• A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function

  2001cited by this paper
• Anthracycline-induced cardiomyopathy.

  2001cited by this paper
• Doxorubicin-Induced Cardiomyopathy

  2000cited by this paper
• Vascular Endothelial Growth Factor Governs Endothelial Nitric-oxide Synthase Expression via a KDR/Flk-1 Receptor and a Protein Kinase C Signaling Pathway*

  1999cited by this paper
• Doxorubicin-induced cardiomyopathy.

  1998cited by this paper
• Cross-sectional echocardiography. III. Analysis of mathematic models for quantifying volume of symmetric and asymmetric left ventricles.

  1980cited by this paper
• Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.

  1979cited by this paper
• A clinicopathologic analysis of adriamycin cardiotoxicity

  1973cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Delving into the pinnacle: an in-depth analysis of the top 100 most cited articles on cardio-oncology

  2025cites this paper
• Evaluating the use of rodents as in vitro, in vivo and ex vivo experimental models for the assessment of tyrosine kinase inhibitor-induced cardiotoxicity: a systematic review

  2025influential citation
• Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective.

  2025cites this paper
• Therapy-naïve malignancy causes cardiovascular disease: A state-of-the-art cardio-oncology perspective.

  2024cites this paper
• Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review

  2024cites this paper
• Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors.

  2024cites this paper
• An overview on the protective effects of ellagic acid against heavy metals, drugs, and chemicals

  2023cites this paper
• A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related Myocarditis

  2022cites this paper
• In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation

  2022influential citation
• Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes

  2022cites this paper
• Protective effect of adenosine triphosphate and benidipine separately or together against cardiotoxicity caused by bevacizumab

  2022cites this paper
• Cardio-Oncology Preclinical Models: A Comprehensive Review

  2021cites this paper
• Bevacizumab as a monoclonal antibody inhibits mitochondrial complex II in isolated rat heart mitochondria: ameliorative effect of ellagic acid

  2020cites this paper
• Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care

  2020cites this paper
• Cardio-Oncology: A Tale of Two Cities: The art of preventing broken hearts in women with breast cancer.

  2019cites this paper
• Lipopolysaccharide-Binding Protein Is an Early Biomarker of Cardiac Function After Radiation Therapy for Breast Cancer.

  2019cites this paper
• miR-140-5p mediates bevacizumab-induced cytotoxicity to cardiomyocytes by targeting the VEGFA/14-3-3γ signal pathway.

  2019cites this paper
• Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.

  2019cites this paper
• Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers

  2019cites this paper
• Carnitine Supplementation Attenuates Sunitinib-Induced Inhibition of AMP-Activated Protein Kinase Downstream Signals in Cardiac Tissues

  2019cites this paper
• Reduction of myocardial ischaemia–reperfusion injury by inactivating oxidized phospholipids

  2018cites this paper
• Cardiotoxicity of Drugs

  2018cites this paper
• Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway

  2018cites this paper
• Sunitinib does not acutely alter left ventricular systolic function, but induces diastolic dysfunction

  2018cites this paper
• Cardiotoxicity with vascular endothelial growth factor inhibitor therapy

  2018cites this paper
• A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate

  2017cites this paper
• Biomarkers for monitoring chemotherapy-induced cardiotoxicity

  2017cites this paper
• Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion

  2017cites this paper
• Oxidative Modifications of Apolipoprotein(a): Implications for Proinflammatory and Prothrombotic Roles of Lipoprotein(a) in the Vasculature

  2016cites this paper
• Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure

  2016cites this paper
• The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries.

  2016cites this paper
• Identification of Oxidized Phosphatidylinositols Present in OxLDL and Human Atherosclerotic Plaque

  2016cites this paper
• Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans

  2016cites this paper
• Loss of Notch3 Signaling in Vascular Smooth Muscle Cells Promotes Severe Heart Failure Upon Hypertension

  2016cites this paper
• Cardiac troponins—Translational biomarkers in cardiology: Theory and practice of cardiac troponin high‐sensitivity assays

  2016cites this paper
• Cardiac Imaging 2015: A Selection of Topical Issues.

  2016cites this paper
• Effects of ionizing radiation on the heart.

  2016cites this paper
• Effects of local irradiation combined with sunitinib on early remodeling, mitochondria, and oxidative stress in the rat heart.

  2016cites this paper
• Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic

  2016cites this paper
• Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues

  2016cites this paper
• Fatal acute cardiac vasculopathy during cisplatin-gemcitabine-bevacizumab (CGB) chemotherapy for advanced urothelial carcinoma.

  2016cites this paper
• Selección de temas de actualidad en imagen cardiaca 2015

  2016cites this paper
• Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors

  2016cites this paper
• Individual response to ionizing radiation.

  2016cites this paper
• Prevention, Detection, and Management of Chemotherapy-Related Cardiac Dysfunction.

  2016cites this paper
• Letter to the Editor: Giant proteins and cancer chemotherapy cardiotoxicity.

  2015cites this paper
• Risk of Selected Cardiovascular Toxicities in Patients With Cancer Treated With MEK Inhibitors: A Comparative Systematic Review and Meta-Analysis

  2015cites this paper
• Mitochondria in Cardiovascular Physiology and Disease Drug-induced mitochondrial dysfunction and cardiotoxicity

  2015cites this paper
• ATVB IN FOCUS: Cardio-Oncology and Vascular Diseases

  year unknowncites this paper